Trial Outcomes & Findings for Measuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst Scaling (NCT NCT02637609)

NCT ID: NCT02637609

Last Updated: 2025-01-24

Results Overview

Average Likert score or best-worst score that measures the impact of each factor on diabetes self-management. Positive scores indicate facilitators for diabetes self-management while negative scores indicate barriers. The magnitude of the score suggests the degree of the impact. Both scales are on a +1--1 scale. Positive 1 would be the largest possible facilitator and a negative 1 would be the largest possible barrier.

Recruitment status

COMPLETED

Target enrollment

1103 participants

Primary outcome timeframe

One-time survey

Results posted on

2025-01-24

Participant Flow

The survey was conducted through GfK KnowledgePanel. Eligible members were invited by email to participate in the survey. All participants were required to be 18 years or older with self-reported physician-diagnosed type 2 diabetes and able to read English or Spanish. African Americans and Latinos were oversampled.

638 respondents (34%) did not respond to the survey and 139 people among those who responded (11%) were excluded based on the screening questions.

Participant milestones

Participant milestones
Measure
Likert Scale
Priority elicitation survey using a Likert scale method. Likert Scale: Respondents receive questions asking them to rate each barrier or facilitator for diabetes self-management.
Best-Worst Scaling (Case 1)
Priority elicitation survey using a best-worst scaling method. Best-Worst Scaling (Case 1): Respondents receive questions asking them to choose the best and worst factors that affect their diabetes self-management among a list of barriers and facilitators.
Overall Study
STARTED
549
554
Overall Study
COMPLETED
549
554
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Measuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst Scaling

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Likert Scale
n=549 Participants
Priority measured by Likert scale Likert Scale: Respondents receive questions asking them to rate each barrier or facilitator for diabetes self-management.
Best-Worst Scaling (Case 1)
n=554 Participants
Priority measured by Best-Worse Scaling (BWS) Best-Worst Scaling (Case 1): Respondents receive questions asking them to choose the best and worst factors that affect their diabetes self-management among a list of barriers and facilitators.
Total
n=1103 Participants
Total of all reporting groups
Age, Continuous
62.29 years
n=5 Participants
61.57 years
n=7 Participants
61.93 years
n=5 Participants
Sex: Female, Male
Female
263 Participants
n=5 Participants
290 Participants
n=7 Participants
553 Participants
n=5 Participants
Sex: Female, Male
Male
286 Participants
n=5 Participants
264 Participants
n=7 Participants
550 Participants
n=5 Participants
Race/Ethnicity, Customized
White, Non-Hispanic
287 Participants
n=5 Participants
288 Participants
n=7 Participants
575 Participants
n=5 Participants
Race/Ethnicity, Customized
Black, Non-Hispanic
126 Participants
n=5 Participants
128 Participants
n=7 Participants
254 Participants
n=5 Participants
Race/Ethnicity, Customized
Other, Non-Hispanic
12 Participants
n=5 Participants
11 Participants
n=7 Participants
23 Participants
n=5 Participants
Race/Ethnicity, Customized
Hispanic
117 Participants
n=5 Participants
119 Participants
n=7 Participants
236 Participants
n=5 Participants
Race/Ethnicity, Customized
2+ Races, Non-Hispanic
7 Participants
n=5 Participants
8 Participants
n=7 Participants
15 Participants
n=5 Participants
Region of Enrollment
United States
549 Participants
n=5 Participants
554 Participants
n=7 Participants
1103 Participants
n=5 Participants
Education
Less than high school
44 Participants
n=5 Participants
38 Participants
n=7 Participants
82 Participants
n=5 Participants
Education
High school
189 Participants
n=5 Participants
173 Participants
n=7 Participants
362 Participants
n=5 Participants
Education
Some college
163 Participants
n=5 Participants
175 Participants
n=7 Participants
338 Participants
n=5 Participants
Education
Bachelor's degree or higher
153 Participants
n=5 Participants
168 Participants
n=7 Participants
321 Participants
n=5 Participants
Income
Less than $25,000
132 Participants
n=5 Participants
141 Participants
n=7 Participants
273 Participants
n=5 Participants
Income
$25,000 - $49,999
156 Participants
n=5 Participants
152 Participants
n=7 Participants
308 Participants
n=5 Participants
Income
$50,000 - $74,999
106 Participants
n=5 Participants
116 Participants
n=7 Participants
222 Participants
n=5 Participants
Income
$75,000 and above
155 Participants
n=5 Participants
145 Participants
n=7 Participants
300 Participants
n=5 Participants
Years of diagnosis
11.54 years
STANDARD_DEVIATION 8.07 • n=5 Participants
11.17 years
STANDARD_DEVIATION 7.99 • n=7 Participants
11.35 years
STANDARD_DEVIATION 8.03 • n=5 Participants
Self-reported health
Excellent
35 Participants
n=5 Participants
25 Participants
n=7 Participants
60 Participants
n=5 Participants
Self-reported health
Very good
170 Participants
n=5 Participants
146 Participants
n=7 Participants
316 Participants
n=5 Participants
Self-reported health
Good
227 Participants
n=5 Participants
238 Participants
n=7 Participants
465 Participants
n=5 Participants
Self-reported health
Fair
88 Participants
n=5 Participants
121 Participants
n=7 Participants
209 Participants
n=5 Participants
Self-reported health
Poor
29 Participants
n=5 Participants
24 Participants
n=7 Participants
53 Participants
n=5 Participants
No. of hypoglycemic events in the past 6 months
None
279 Participants
n=5 Participants
292 Participants
n=7 Participants
571 Participants
n=5 Participants
No. of hypoglycemic events in the past 6 months
1 time
80 Participants
n=5 Participants
80 Participants
n=7 Participants
160 Participants
n=5 Participants
No. of hypoglycemic events in the past 6 months
2-5 times
147 Participants
n=5 Participants
131 Participants
n=7 Participants
278 Participants
n=5 Participants
No. of hypoglycemic events in the past 6 months
More than 5 times
43 Participants
n=5 Participants
51 Participants
n=7 Participants
94 Participants
n=5 Participants
No. of HbA1c level measured in past 6 months
None
30 Participants
n=5 Participants
42 Participants
n=7 Participants
72 Participants
n=5 Participants
No. of HbA1c level measured in past 6 months
1 time
243 Participants
n=5 Participants
249 Participants
n=7 Participants
492 Participants
n=5 Participants
No. of HbA1c level measured in past 6 months
More than 2 times
257 Participants
n=5 Participants
250 Participants
n=7 Participants
507 Participants
n=5 Participants
No. of HbA1c level measured in past 6 months
Don't know
19 Participants
n=5 Participants
13 Participants
n=7 Participants
32 Participants
n=5 Participants
Most recent HbA1c level
Over 9.0%
23 Participants
n=5 Participants
35 Participants
n=7 Participants
58 Participants
n=5 Participants
Most recent HbA1c level
Over 8.0% but under 9.0%
52 Participants
n=5 Participants
53 Participants
n=7 Participants
105 Participants
n=5 Participants
Most recent HbA1c level
Over 7.0% but under 8.0%
149 Participants
n=5 Participants
148 Participants
n=7 Participants
297 Participants
n=5 Participants
Most recent HbA1c level
Under 7.0%
242 Participants
n=5 Participants
218 Participants
n=7 Participants
460 Participants
n=5 Participants
Most recent HbA1c level
Don't know
83 Participants
n=5 Participants
100 Participants
n=7 Participants
183 Participants
n=5 Participants
Type of diabetes medicine used
No prescription medicine
52 Participants
n=5 Participants
47 Participants
n=7 Participants
99 Participants
n=5 Participants
Type of diabetes medicine used
Only pills
333 Participants
n=5 Participants
333 Participants
n=7 Participants
666 Participants
n=5 Participants
Type of diabetes medicine used
Only injections/shots
48 Participants
n=5 Participants
42 Participants
n=7 Participants
90 Participants
n=5 Participants
Type of diabetes medicine used
Pills and injections/shots
115 Participants
n=5 Participants
131 Participants
n=7 Participants
246 Participants
n=5 Participants
Type of diabetes medicine used
Refused
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Complications
Yes
233 Participants
n=5 Participants
230 Participants
n=7 Participants
463 Participants
n=5 Participants
Complications
No
316 Participants
n=5 Participants
324 Participants
n=7 Participants
640 Participants
n=5 Participants
Other chronic conditions
Yes
451 Participants
n=5 Participants
470 Participants
n=7 Participants
921 Participants
n=5 Participants
Other chronic conditions
No
98 Participants
n=5 Participants
84 Participants
n=7 Participants
182 Participants
n=5 Participants

PRIMARY outcome

Timeframe: One-time survey

Population: Respondents who completed the survey.

Average Likert score or best-worst score that measures the impact of each factor on diabetes self-management. Positive scores indicate facilitators for diabetes self-management while negative scores indicate barriers. The magnitude of the score suggests the degree of the impact. Both scales are on a +1--1 scale. Positive 1 would be the largest possible facilitator and a negative 1 would be the largest possible barrier.

Outcome measures

Outcome measures
Measure
Likert Scale
n=549 Participants
Priority measured by 5-point Likert scale Likert Scale: Respondents receive questions asking them to rate each barrier or facilitator for diabetes self-management.
Best-Worst Scaling (Case 1)
n=554 Participants
Priority measured by best-worst scaling Best-Worst Scaling (Case 1): Respondents receive questions asking them to choose the best and worst factors that affect their diabetes self-management among a list of barriers and facilitators.
Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management
Healthcare providers
0.505 units on a scale
Interval 0.433 to 0.577
0.327 units on a scale
Interval 0.306 to 0.349
Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management
My own knowledge
0.500 units on a scale
Interval 0.437 to 0.563
0.369 units on a scale
Interval 0.346 to 0.392
Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management
Access to healthy food
0.439 units on a scale
Interval 0.367 to 0.51
0.211 units on a scale
Interval 0.187 to 0.235
Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management
Support from others
0.359 units on a scale
Interval 0.291 to 0.426
0.058 units on a scale
Interval 0.035 to 0.08
Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management
Staying motivated
0.344 units on a scale
Interval 0.264 to 0.424
0.019 units on a scale
Interval -0.009 to 0.048
Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management
Family commitments
0.293 units on a scale
Interval 0.22 to 0.366
0.002 units on a scale
Interval -0.018 to 0.022
Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management
Physical environment
0.287 units on a scale
Interval 0.215 to 0.358
-0.079 units on a scale
Interval -0.1 to -0.059
Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management
My ability to pay
0.207 units on a scale
Interval 0.119 to 0.295
-0.166 units on a scale
Interval -0.189 to -0.143
Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management
Local events
0.087 units on a scale
Interval 0.029 to 0.145
-0.236 units on a scale
Interval -0.255 to -0.217
Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management
Work commitments
0.082 units on a scale
Interval 0.011 to 0.153
-0.217 units on a scale
Interval -0.235 to -0.199
Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management
Other health conditions
0.067 units on a scale
Interval -0.013 to 0.147
-0.281 units on a scale
Interval -0.303 to -0.259

SECONDARY outcome

Timeframe: One-time survey

Population: Respondents who completed the survey.

Questions that asked respondents to evaluate whether it was easy to understand and answer the Likert scale or BWS tasks.

Outcome measures

Outcome measures
Measure
Likert Scale
n=549 Participants
Priority measured by 5-point Likert scale Likert Scale: Respondents receive questions asking them to rate each barrier or facilitator for diabetes self-management.
Best-Worst Scaling (Case 1)
n=554 Participants
Priority measured by best-worst scaling Best-Worst Scaling (Case 1): Respondents receive questions asking them to choose the best and worst factors that affect their diabetes self-management among a list of barriers and facilitators.
Self-reported Difficulty in Understanding and Answering the Survey Questions
My answers are consistent with my preferences · Strongly agree
130 Participants
99 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
I found it easy to understand the questions · Strongly disagree
10 Participants
26 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
I found it easy to understand the questions · Disagree
23 Participants
90 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
I found it easy to understand the questions · Neither agree nor disagree
73 Participants
141 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
I found it easy to understand the questions · Agree
316 Participants
224 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
I found it easy to understand the questions · Strongly agree
122 Participants
71 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
I found it easy to understand the questions · Refused
5 Participants
2 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
I found it easy to answer all the questions · Strongly disagree
9 Participants
34 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
I found it easy to answer all the questions · Disagree
33 Participants
97 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
I found it easy to answer all the questions · Neither agree nor disagree
71 Participants
160 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
I found it easy to answer all the questions · Agree
317 Participants
196 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
I found it easy to answer all the questions · Strongly agree
113 Participants
66 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
I found it easy to answer all the questions · Refused
6 Participants
1 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
My answers are consistent with my preferences · Strongly disagree
6 Participants
6 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
My answers are consistent with my preferences · Disagree
8 Participants
13 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
My answers are consistent with my preferences · Neither agree nor disagree
61 Participants
130 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
My answers are consistent with my preferences · Agree
338 Participants
306 Participants
Self-reported Difficulty in Understanding and Answering the Survey Questions
My answers are consistent with my preferences · Refused
6 Participants
0 Participants

Adverse Events

Likert Scale

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Best-Worst Scaling (Case 1)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

John FP Bridges

Johns Hopkins Bloomberg School of Public Health

Phone: 614-685-2543

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place